Literature DB >> 16207876

Ribosome dysfunction is an early event in Alzheimer's disease.

Qunxing Ding1, William R Markesbery, Qinghua Chen, Feng Li, Jeffrey N Keller.   

Abstract

Alzheimer's disease (AD) is a progressive and devastating disorder that is often preceded by mild cognitive impairment (MCI). In the present study, we report that in multiple cortical areas of MCI and AD subjects, there is a significant impairment in ribosome function that is not observed in the cerebellum of the same subjects. The impairment in ribosome function is associated with a decreased rate and capacity for protein synthesis, decreased ribosomal RNA and tRNA levels, and increased RNA oxidation. No alteration in the level of initiation factors was observed in the brain regions exhibiting impairments in protein synthesis. Together, these data indicate for the first time that impairments in protein synthesis may be one of the earliest neurochemical alterations in AD and directly demonstrate that the polyribosome complex is adversely affected early in the development of AD. These data have important implications for AD studies involving proteomics and studies analyzing proteolysis in AD, indicate that oxidative damage may contribute to decreased protein synthesis, and suggest a role for alterations in protein synthesis as a novel contributor to the onset and development of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207876      PMCID: PMC6725754          DOI: 10.1523/JNEUROSCI.3040-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  31 in total

Review 1.  Ribosome assembly in eukaryotes.

Authors:  Micheline Fromont-Racine; Bruno Senger; Cosmin Saveanu; Franco Fasiolo
Journal:  Gene       Date:  2003-08-14       Impact factor: 3.688

Review 2.  Mammalian aminoacyl-tRNA synthetases.

Authors:  D C Yang
Journal:  Curr Top Cell Regul       Date:  1996

3.  Mild cognitive impairment in the elderly: predictors of dementia.

Authors:  C Flicker; S H Ferris; B Reisberg
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

4.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

5.  Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.

Authors:  S Seshadri; P A Wolf; A Beiser; R Au; K McNulty; R White; R B D'Agostino
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

6.  Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures.

Authors:  Qunxing Ding; Edgardo Dimayuga; William R Markesbery; Jeffrey N Keller
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

7.  RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

Authors:  A Nunomura; G Perry; M A Pappolla; R Wade; K Hirai; S Chiba; M A Smith
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

Review 8.  Mild cognitive impairment: directions for future research.

Authors:  C A Luis; D A Loewenstein; A Acevedo; W W Barker; R Duara
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

9.  Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.

Authors:  I Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2002-12       Impact factor: 8.090

Review 10.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

View more
  146 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage.

Authors:  Maciej Pietrzak; Scott C Smith; Justin T Geralds; Theo Hagg; Cynthia Gomes; Michal Hetman
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

3.  RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondria.

Authors:  Mikiei Tanaka; Pawel Jaruga; Pascal A Küpfer; Christian J Leumann; Miral Dizdaroglu; William E Sonntag; P Boon Chock
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

Review 4.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

5.  Lessons in the study of Alzheimer's disease: a tribute to Dr. William R. Markesbery.

Authors:  Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Neuromolecular Med       Date:  2010-07-17       Impact factor: 3.843

6.  Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy.

Authors:  Boris Görg; Natalia Qvartskhava; Hans-Jürgen Bidmon; Nicola Palomero-Gallagher; Gerald Kircheis; Karl Zilles; Dieter Häussinger
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

Review 7.  Emerging roles of the neuronal nucleolus.

Authors:  Michal Hetman; Maciej Pietrzak
Journal:  Trends Neurosci       Date:  2012-02-02       Impact factor: 13.837

Review 8.  Ribosomopathies: Old Concepts, New Controversies.

Authors:  Katherine I Farley-Barnes; Lisa M Ogawa; Susan J Baserga
Journal:  Trends Genet       Date:  2019-07-31       Impact factor: 11.639

Review 9.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

10.  Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.

Authors:  Rukhsana Sultana; William A Banks; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2010-02-15       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.